Cancellation of state registration. Tanise® ERAS

February 08, 2018
Active substances:
Trade names:
ICD-10:
XIV.N40-N51.N40    Hyperplasia of the prostate
Tanis ERAS, tamsulosin, prostatic hyperplasia, prostate gland

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LP-002086 from 06/03/2013, issued by KRKA-RUS LLC, Russia):

Tanise® ERAS (trade name of the medicinal product)

Tamsulosin (an international non-proprietary or chemical name for a medicinal product)

tablets, with prolonged release, coated with film shell, 0.4 mg (dosage form, dosage)

OOO "KRKA-RUS", Russia 143500, Moscow Region, Istra, ul. Moscow, 50 (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the authorized legal entity of the representative office of the company "KRKA-RUS", Russia, a statement on the cancellation of the state registration of the medicinal product.